Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
24 participants
INTERVENTIONAL
2024-11-30
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* The aim of the current study is to assess immediate dental implant stability coated with erythropoietin gel, both clinically and radiographically.
* Materials and Methods: We conducted a randomized controlled clinical trial.The sample will include patients demanding immediate implant treatment in the anterior maxilla . Patients will be randomly allocated into the two groups of the study. The group A will be treated with erythropoietin gel coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla . Group B will be treated with non coated dental implant immediately after extraction of non restorable teeth in the anterior maxilla .
* The primary outcome variable will be implant stability and the secondary outcome will be crestal marginal bone level and bone density around implants. It will be measured at time of implant placement and reevaluated after 6-months .
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Crestal Bone Level After Allogenic Bone Ring With Simultaneous Dental Implant Placement
NCT03906591
Stability of Patient-specific Root-analogue Implants and Conventional Root-form Implants for Treating Non-restorable Single-rooted Maxillary Teeth
NCT03689933
Effect of Concentrated Growth Factors on Short Implant-Supported Overdentures
NCT06880965
Evaluation of the Effect of Low Level Laser Therapy on Crestal Bone Changes and Secondary Stability Around Delayed Implant
NCT06666062
Using Two Different Attachments in Mandibular Implant Overdenture Cases in Order to Retention and Patient Satisfaction
NCT06678945
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Test Group
Patients with fresh extraction sockets in the anterior maxilla will be treated by immediate implant coated by erythropoietin gel .
Erythropoietin gel coated implants
Patients with fresh extraction sockets in the anterior maxilla will be treated by immediate implant coated by erythropoietin gel.
Control group
Patients with fresh extraction sockets in the anterior maxilla will be treated by non coated immediate implant .
Non coated dental implants
Patients with fresh extraction sockets in the anterior maxilla will be treated by non coated immediate implant .
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non coated dental implants
Patients with fresh extraction sockets in the anterior maxilla will be treated by non coated immediate implant .
Erythropoietin gel coated implants
Patients with fresh extraction sockets in the anterior maxilla will be treated by immediate implant coated by erythropoietin gel.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Good general periodontal health and maintenance.
Exclusion Criteria
* Acute infected socket
* Ant socket with wall defect.
* Pregnency
* Local or systemic conditions that will interfere with bone healing (uncontrolled diabetes mellitus or human immune deficiency virus infections, resonance therapy), bone disorders (hyperparathyroidism, osteoporosis, or Paget's disease.
* Patients who had subjected to intravenous and/or oral bisphosphonate therapy.
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Al-Azhar University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mohsen Farghaly
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mohamed Alaa Lecturer of OMFS
Role: STUDY_DIRECTOR
faculty of Dental medicine Al-Azhar University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of dental medicine Al-Azhar university
Asyut, Asyut Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Mohamed Mahjob Head of oral and maxillofacial surgery department
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Mohamed Mahjob Head of oral and maxillofacial surgery department
Role: primary
Mohamed Alaa Lecturer of OMFS
Role: backup
Ahmed Mohsen Principle investigator
Role: backup
Mohamed Mahjob Head of oral and maxillofacial surgery department
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Implant surface modification
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.